Virtual screening approaches are becoming a more essential tool for finding leads. VS is a computational technique that searches virtual fragment libraries for probable hits using computer algorithms. VS is a computational technique that uses a large and diverse library of chemical compounds to discover lead molecules. In comparison to an experimental strategy such as high-throughput screening, VS is a crucial technique for creating lead compounds since it is faster, more cost-effective, and less resource-intensive. Virtual screening has grown in popularity as a technique for developing alternative ways for choosing an appropriate selection of compounds, minimizing excessive resource expenses, and preventing the generation of unwanted compounds. Virtual screening has the potential to play a unique role in studying the interactions of all existing natural compounds with all potential targets. Virtual screening, which uses either structure-based approaches (protein structure or homology model with known/identified binding site) or ligand-based approaches to find novel hits, is a strong way to find new hits (chemical structures of known modulators of the target).
Title : A qsar survey on tyrosine kinase inhibitors
Atefeh Hajiagha Bozorgi, Faculty of pharmacy, Iran (Islamic Republic of)
Title : Abbott diagnostics: COVID-19 inactivation, nucleocapsid antigen automated immunoassay development, and variant testing for automated and lateral flow assays binaxnow™ and panbio™
Philip M Hemken, Abbott Laboratories, United States
Title : Synthesis, antibacterial activity of 3-amino 5-methoxyl-2-methyl quinazolin-4(3H)-one an amino-6-methoxyl-2-methyl of 4H–benzo[d] [1,3]–oxazine–4–one
Osarumwense Peter Osarodion, Ondo State University of Sciences and Technology, Nigeria
Title : Tackling mycobacterium tuberculosis resistance with tailored isatin-pyrimidine hybrids enoyl acyl carrier protein reductase (Inha)
Amgad Albohy, The British University in Egypt (BUE), Egypt
Title : Transition metal complexes/Organometallic compounfs as anticancer drugs
Prakash kinthda, Nims university,jaipur,rajasthan, India
Title : New n-ribosides and n-mannosides of rhodanine derivatives with anticancer activity on leukaemia cell line: Design, synthesis, dft and molecular modelling studies
Ahmed, Kafrelsheikh University, Egypt